ASO Visual Abstract: Clinical Outcomes of First-Line Immune Checkpoint Inhibitor-Based Therapy for Postoperative Recurrence After Adjuvant Nivolumab in Esophageal Cancer
Authors: Takahito Sugase, Takashi Kanemura, Norihiro Matsuura et al.
Publication: Annals of Surgical Oncology
Published: Jun 17, 2026
Source: Crossref